The MedTech and BioTech track is designed for projects operating at the intersection of medicine, pharmaceuticals, IT, and engineering. Participants may include teams developing medical devices, diagnostic systems, digital healthcare platforms, wearable electronics, pharmaceutical products, as well as solutions in bioengineering and cellular technologies.
The program focuses on accelerated hypothesis validation, biological and clinical significance testing, certification preparation, and market entry. Startups gain access to the infrastructure of the Saint Petersburg Technopark and partner laboratories, as well as regulatory consulting, intellectual property protection, grant acquisition, and piloting in medical institutions.
The track is particularly beneficial for projects at the MVP or clinical trial stage seeking technological and entrepreneurial growth in a highly regulated environment.